Tdam USA Inc. trimmed its stake in shares of Danaher Co. (NYSE:DHR) by 2.1% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 127,404 shares of the conglomerate’s stock after selling 2,772 shares during the quarter. Tdam USA Inc.’s holdings in Danaher were worth $13,138,000 as of its most recent SEC filing.
Several other large investors also recently added to or reduced their stakes in DHR. Ruggie Capital Group bought a new position in Danaher in the 4th quarter worth about $40,000. We Are One Seven LLC bought a new position in Danaher in the 4th quarter worth about $44,000. Legacy Financial Advisors Inc. increased its stake in Danaher by 59.4% in the 4th quarter. Legacy Financial Advisors Inc. now owns 690 shares of the conglomerate’s stock worth $71,000 after acquiring an additional 257 shares during the last quarter. NuWave Investment Management LLC increased its stake in Danaher by 5,600.0% in the 4th quarter. NuWave Investment Management LLC now owns 798 shares of the conglomerate’s stock worth $82,000 after acquiring an additional 784 shares during the last quarter. Finally, Parkside Financial Bank & Trust boosted its holdings in shares of Danaher by 76.7% in the 4th quarter. Parkside Financial Bank & Trust now owns 1,016 shares of the conglomerate’s stock worth $105,000 after purchasing an additional 441 shares in the last quarter. Institutional investors own 77.05% of the company’s stock.
DHR has been the subject of a number of research reports. Royal Bank of Canada reiterated a “hold” rating and issued a $102.00 price objective on shares of Danaher in a report on Wednesday, December 19th. Needham & Company LLC initiated coverage on Danaher in a report on Wednesday, January 2nd. They issued a “buy” rating and a $114.00 price objective for the company. Zacks Investment Research cut Danaher from a “buy” rating to a “hold” rating in a report on Friday, October 12th. Cowen reiterated a “buy” rating and issued a $110.00 price objective on shares of Danaher in a report on Monday, January 7th. Finally, Robert W. Baird cut their price objective on Danaher from $116.00 to $114.00 and set an “outperform” rating for the company in a report on Friday, October 19th. Two analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company. The stock presently has a consensus rating of “Buy” and an average price target of $113.08.
Shares of DHR stock opened at $109.25 on Friday. The stock has a market cap of $76.11 billion, a P/E ratio of 24.17, a P/E/G ratio of 2.00 and a beta of 0.99. Danaher Co. has a 1-year low of $91.84 and a 1-year high of $111.10. The company has a debt-to-equity ratio of 0.34, a current ratio of 1.47 and a quick ratio of 1.07.
Danaher (NYSE:DHR) last issued its earnings results on Tuesday, January 29th. The conglomerate reported $1.28 earnings per share for the quarter, beating the consensus estimate of $1.27 by $0.01. The company had revenue of $5.40 billion during the quarter, compared to analysts’ expectations of $5.33 billion. Danaher had a return on equity of 11.64% and a net margin of 13.33%. Danaher’s quarterly revenue was up 6.2% compared to the same quarter last year. During the same period in the prior year, the business posted $1.19 EPS. As a group, equities research analysts expect that Danaher Co. will post 4.78 EPS for the current fiscal year.
The business also recently announced a quarterly dividend, which was paid on Friday, January 25th. Investors of record on Friday, December 28th were issued a dividend of $0.16 per share. This represents a $0.64 annualized dividend and a yield of 0.59%. The ex-dividend date of this dividend was Thursday, December 27th. Danaher’s dividend payout ratio is presently 14.16%.
WARNING: This report was first published by Highlight Press and is the sole property of of Highlight Press. If you are viewing this report on another domain, it was stolen and reposted in violation of US & international trademark and copyright law. The original version of this report can be accessed at https://highlightpress.com/2019/02/09/tdam-usa-inc-has-13-14-million-position-in-danaher-co-dhr.html.
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides laser scanning, compound, surgical, and other stereo microscopes. This segment also offers filtration, separation, and purification technologies to the biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial sectors.
Recommended Story: What are municipal bonds?
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.